F.D.A. Reinstates Fired Medical Device, Food and Legal Staffers
The agency changed course just days after firing employees who oversee the safety of food and life-sustaining medical devices ...
FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect
The FDA's new standards for foods before they can be labeled as "healthy" on their packaging will go into effect about two ...
FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
Gilead’s lenacapavir under priority review could revolutionise HIV PrEP
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...
USA Today4d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The Food and Drug Administration on Friday said the shortage of Novo Nordisk's weight-loss and diabetes drugs Wegovy and Ozempic is resolved, a move that could limit the availability of cheaper ...
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
JD Supra1d
FDA Reveals AI Development Cheat Sheet in Highly Anticipated Draft Guidances
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial ...
PharmiWeb6d
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...
Trump is firing federal workers who are not funded by taxpayers
A lawyer for Luigi Mangione, the man accused of fatally gunning down U.S. health insurance executive Brian Thompson in ...
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...
manilatimes1d
XORTX Commences Gout Program NDA Discussions with the FDA
● Type C Meeting Requested to Accelerate XRx-026 for Gout to NDA ● ...
USA Today5d
NBA suspends Bucks forward Bobby Portis 25 games for violating anti-drug policy
"This was, again, an honest mistake that was made because of the similarity in the names of the drugs and the fact they both serve a very similar purpose ... by The Food and Drug Administration ...